Javier Huarte
Global Guide 2024
Band 1 : Intellectual Property: Patents
Band 1
About
Provided by Javier Huarte
Practice Areas
Javier Huarte is one of the country’s most experienced and active patent litigators with more than 21 years’ experience representing a wide range of pharmaceutical companies in complex disputes concerning generics and blockbuster drug patents.
He has an extensive knowledge of European patent law, regularly setting precedents in pan European pharma patent litigations.
He also works in patent matters and court cases relating to biologic innovative products and biosimilars, acting for clients including leading global drug companies, in some highly sophisticated cases.. He has attained many landmark victories in court cases involving blockbuster drugs such as Zocor® (simvastatin), Cipralex® (escitalopram), Viagra® (sildenafil), Lyrica® (pregabalin), Exelon® (rivastigmine), Yasminelle® (drospirenone), Seroquel® (quetiapine), Bonviva® (ibandronate), Tracleer® (bosentan), Exforge® (valsartan/amlodipine), Truvada® (tenofovir/emtricitabine), Inegy® (ezetimibe/simvastatin), Nexavar® (sorafenib) and many more.
Career
Javier joined Grau & Angulo in 2003 and has been a partner since 2005.
He leads the firm’s team for advice and litigation on pharmaceutical patents. He has formed an excellent portfolio of clients and for over twenty years he has acted in some of the most groundbreaking pharmaceutical patent cases in Spain.
Professional Memberships
He is a Member of the Barcelona Bar Association and AIPPI.
Chambers Review
Global
Javier Huarte is identified as a leading figure in patent litigation relating to generic drugs. He enjoys a broad client base in the pharmaceutical industry given his considerable experience.
Strengths
Provided by Chambers
"We work with Javier Huarte due to his speed in handling matters, his brilliant performance in court and his business-oriented mind."
"We work with Javier Huarte due to his speed in handling matters, his brilliant performance in court and his business-oriented mind."